In our own discovery sample set of EOC tumors, while not reaching statistical significance, we did find an interesting trend of higher CD151 expression in primary ovarian tumors and relatively lower expression in disseminated metastatic or recurrent disease (Tables 1 and 2 ).
← all excerpts
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer.
1
—
—